Fibromyalgia
Conditions
Brief summary
This clinical cross-sectional study will include 86 female patients aged between 18 and 65 years who have been diagnosed with fibromyalgia syndrome according to the 2010 American College of Rheumatology diagnostic criteria and 86 female patients for control group. Sociodemographic data will be recorded at the beginning of the study. Pain severity will be assessed using the Visual Analog Scale (VAS). Orthorexia nervosa-related symptoms will be evaluated with the ORTO-11 scale. Body image will be assessed with the Body Appreciation Scale 2, mood will be evaluated using the Hospital Anxiety and Depression Scale (HADS), and fibromyalgia-related impact will be assessed with the Fibromyalgia Impact Questionnaire (FIQ).
Interventions
OTHERFibromyalgia
no intervention
Sponsors
Beylikduzu State Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 65 Years
Inclusion criteria
* Female patients aged 18-65 years. * Diagnosis of fibromyalgia syndrome according to the 2010 American College of Rheumatology diagnostic criteria. * Willingness to participate and provision of written informed consent.
Exclusion criteria
* Refusal to participate. * Presence of diagnosed psychiatric disorders. * Presence of cognitive impairment. * Use of medications that may affect mood.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| ORTO-11 Scale | Baseline | The ORTO-11 assesses orthorexic tendencies, which refer to an unhealthy obsession with healthy eating. It consists of 11 items rated on a 4-point Likert scale. Total scores range from 11 to 44, with lower scores indicating a higher risk of orthorexia nervosa. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Hospital Anxiety Scale (HADS-A): | Baseline | The HADS-A subscale evaluates symptoms of anxiety. It consists of 7 items, each scored between 0 and 3. The total score ranges from 0 to 21, with higher scores indicating higher levels of anxiety. |
| Hospital Depression Scale (HADS-D): | Baseline | The HADS-D subscale evaluates symptoms of depression. It consists of 7 items, each scored between 0 and 3. The total score ranges from 0 to 21, with higher scores indicating higher levels of depression. |
| Body Appreciation Scale-2 (BAS-2) | Baseline | The BAS-2 assesses positive body image and appreciation of one's body. It consists of 10 items rated on a 5-point Likert scale (1 = Never, 5 = Always). Total scores range from 10 to 50, with higher scores indicating greater body appreciation. |
| Fibromyalgia Impact Questionnaire (FIQ) | Baseline | The FIQ is a self-reported instrument designed to assess the health status and functional impact of fibromyalgia. It consists of 10 items evaluating physical functioning, work status, depression, anxiety, sleep, pain, stiffness, fatigue, and well-being. The total score ranges from 0 to 100, with higher scores indicating greater functional impairment and symptom severity. |
Countries
Turkey (Türkiye)
Outcome results
None listed